Chen Q, Zheng J, Wang D
World J Stem Cells. 2025; 17(2):103599.
PMID: 40061271
PMC: 11885939.
DOI: 10.4252/wjsc.v17.i2.103599.
Ozturk T, Mignot J, Gattazzo F, Gervais M, Relaix F, Rouard H
Stem Cell Res Ther. 2024; 15(1):179.
PMID: 38902774
PMC: 11191274.
DOI: 10.1186/s13287-024-03795-0.
Haase M, Comlekoglu T, Petrucciani A, Peirce S, Blemker S
Elife. 2024; 13.
PMID: 38828844
PMC: 11147512.
DOI: 10.7554/eLife.91924.
Balayan A, DeBoutray M, Molley T, Ruoss S, Maceda M, Sevier A
Am J Physiol Cell Physiol. 2024; 326(4):C1193-C1202.
PMID: 38581669
PMC: 11193520.
DOI: 10.1152/ajpcell.00023.2024.
Azzag K, Gransee H, Magli A, Yamashita A, Tungtur S, Ahlquist A
Int J Mol Sci. 2024; 25(5).
PMID: 38473751
PMC: 10931593.
DOI: 10.3390/ijms25052503.
CRISPR/Cas9 Genome Editing in LGMD2A/R1 Patient-Derived Induced Pluripotent Stem and Skeletal Muscle Progenitor Cells.
Mavrommatis L, Zaben A, Kindler U, Kienitz M, Dietz J, Jeong H
Stem Cells Int. 2023; 2023:9246825.
PMID: 38020204
PMC: 10653971.
DOI: 10.1155/2023/9246825.
Human skeletal muscle organoids model fetal myogenesis and sustain uncommitted PAX7 myogenic progenitors.
Mavrommatis L, Jeong H, Kindler U, Gomez-Giro G, Kienitz M, Stehling M
Elife. 2023; 12.
PMID: 37963071
PMC: 10645425.
DOI: 10.7554/eLife.87081.
Bioprocessing Considerations towards the Manufacturing of Therapeutic Skeletal and Smooth Muscle Cells.
Franchi-Mendes T, Silva M, Cartaxo A, Fernandes-Platzgummer A, Cabral J, da Silva C
Bioengineering (Basel). 2023; 10(9).
PMID: 37760170
PMC: 10525286.
DOI: 10.3390/bioengineering10091067.
Muscle stem cells and rotator cuff injury.
Gupta R, Rao R, Johnston T, Uong J, Yang D, Lee T
JSES Rev Rep Tech. 2023; 1(3):186-193.
PMID: 37588948
PMC: 10426486.
DOI: 10.1016/j.xrrt.2021.05.001.
Contribution of peripheral blood mononuclear cells isolated by advanced filtration system to myogenesis of human bone marrow mesenchymal stem cells co-cultured with myoblasts.
Scala P, Manzo P, Longo R, Giudice V, Ciardulli M, Serio B
Heliyon. 2023; 9(6):e17141.
PMID: 37484299
PMC: 10361327.
DOI: 10.1016/j.heliyon.2023.e17141.
Loss of transcriptional heterogeneity in aged human muscle stem cells.
Barruet E, Striedinger K, Marangoni P, Pomerantz J
PLoS One. 2023; 18(5):e0285018.
PMID: 37192223
PMC: 10187936.
DOI: 10.1371/journal.pone.0285018.
DNA Methylation Analysis Reveals Distinct Patterns in Satellite Cell-Derived Myogenic Progenitor Cells of Subjects with Spastic Cerebral Palsy.
Robinson K, Marsh A, Lee S, Hicks J, Romero B, Batish M
J Pers Med. 2022; 12(12).
PMID: 36556199
PMC: 9780849.
DOI: 10.3390/jpm12121978.
Human Tissue-Engineered Skeletal Muscle: A Tool for Metabolic Research.
Kim J, Yu S, Son J
Endocrinol Metab (Seoul). 2022; 37(3):408-414.
PMID: 35798547
PMC: 9262682.
DOI: 10.3803/EnM.2022.302.
Development of Therapeutic RNA Manipulation for Muscular Dystrophy.
Saifullah , Motohashi N, Tsukahara T, Aoki Y
Front Genome Ed. 2022; 4:863651.
PMID: 35620642
PMC: 9127466.
DOI: 10.3389/fgeed.2022.863651.
Optimized lentiviral vector to restore full-length dystrophin via a cell-mediated approach in a mouse model of Duchenne muscular dystrophy.
Meng J, Moore M, Counsell J, Muntoni F, Popplewell L, Morgan J
Mol Ther Methods Clin Dev. 2022; 25:491-507.
PMID: 35615709
PMC: 9121076.
DOI: 10.1016/j.omtm.2022.04.015.
Defining the Skeletal Myogenic Lineage in Human Pluripotent Stem Cell-Derived Teratomas.
Pappas M, Xie N, Penaloza J, Chan S
Cells. 2022; 11(9).
PMID: 35563894
PMC: 9102156.
DOI: 10.3390/cells11091589.
Myoblast deactivation within engineered human skeletal muscle creates a transcriptionally heterogeneous population of quiescent satellite-like cells.
Wang J, Broer T, Chavez T, Zhou C, Tran S, Xiang Y
Biomaterials. 2022; 284:121508.
PMID: 35421801
PMC: 9289780.
DOI: 10.1016/j.biomaterials.2022.121508.
mRNA-mediated delivery of gene editing tools to human primary muscle stem cells.
Stadelmann C, Di Francescantonio S, Marg A, Muthel S, Spuler S, Escobar H
Mol Ther Nucleic Acids. 2022; 28:47-57.
PMID: 35356683
PMC: 8931293.
DOI: 10.1016/j.omtn.2022.02.016.
Cell Surface Proteins for Enrichment and Characterization of Human Pluripotent Stem Cell-Derived Myogenic Progenitors.
Tey S, Mueller M, Reilly M, Switalski C, Robertson S, Sakanaka-Yokoyama M
Stem Cells Int. 2022; 2022:2735414.
PMID: 35251185
PMC: 8894063.
DOI: 10.1155/2022/2735414.
Recapitulating human myogenesis ex vivo using human pluripotent stem cells.
Chien P, Xi H, Pyle A
Exp Cell Res. 2022; 411(2):112990.
PMID: 34973262
PMC: 8996775.
DOI: 10.1016/j.yexcr.2021.112990.